• Markets
  • icon
  • Companies
PME · ASX

Pro Medicus, Ltd. (ASX:PME)

AU$116.9

 -2.86 (-2.388%)
ASX:Live
17/05/2024 04:10:34 PM
HALO Price Momentum HALO Ords HALO Dividend Growth HALO Capital Efficiency HALO Balance Sheet +6
Consensus Score
/10
Recommend
Target Price
Deviation
Unlock Full Consensus Insights

PME Overview

PME Health Scores

Short Term

Mean Revision

Neutral

Trend

Neutral

Event

Neutral

Halo Model

MQV

Very Strong

GARP

Very Strong

MQV Small

Neutral

Valuation

Value

Consensus

Momentum

Price

Very Weak

Earnings

Neutral

Growth

Earnings

Neutral

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Weak

About PME

Telephone

Address

Description

Pro Medicus Ltd. provides a range of radiology information technology software and services to hospitals, imaging centers and health care groups. It provides services in the form of installation and support. The firm offers a range of products including radiology information systems, picture archiving and communication systems. It also offers workflow mapping and optimization, network design and implementation, hardware sourcing, and configuration as well as staff and management training. The company was founded by Sam Aaron Hupert and Anthony Barry Hall in 1983 and is headquartered in Richmond, Australia.

PME Price Chart

Key Stats

Market Cap

AU$12.51B

PE

124.40

EV/EBITDA

79.8

Dividends Overview

DIV Yield

.4%

Franking

100%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 58.6 - 121.76

Trade Value (12mth)

AU$5,010,751.00

1 week

3.17%

1 month

13.54%

YTD

21.39%

1 year

93%

All time high

121.76499938964844

Key Fundamentals

EPS 3 yr Growth

161.500%

EBITDA Margin

73.50%

Operating Cashflow

$65m

Free Cash Flow Return

53.20%

ROIC

49.80%

Interest Coverage

N/A

Quick Ratio

5.30

Other Data

Shares on Issue (Fully Dilluted)

105m

HALO Sector

Next Company Report Date

13-Aug-24

Ex Dividend Date (est.)

N/A

Next Dividend Pay Date (est.)

N/A

Reporting Currency

AUD

Short Sell (% of issue)

1.58

PME Announcements

Latest Announcements

Date Announcements

08 May 24

Macquarie Conference May 2024 Presentation

×

Macquarie Conference May 2024 Presentation

02 April 24

Update - Notification of buy-back - PME

×

Update - Notification of buy-back - PME

02 April 24

Notification of buy-back - PME

×

Notification of buy-back - PME

01 March 24

S&P DJI Announces March 2024 Quarterly Rebalance

×

S&P DJI Announces March 2024 Quarterly Rebalance

27 February 24

Notification of cessation of securities - PME

×

Notification of cessation of securities - PME

27 February 24

Notification of cessation of securities - PME

×

Notification of cessation of securities - PME

27 February 24

Notification of cessation of securities - PME

×

Notification of cessation of securities - PME

26 February 24

Update - Notification of buy-back - PME

×

Update - Notification of buy-back - PME

23 February 24

Update - Notification of buy-back - PME

×

Update - Notification of buy-back - PME

22 February 24

Update - Notification of buy-back - PME

×

Update - Notification of buy-back - PME

21 February 24

Update - Notification of buy-back - PME

×

Update - Notification of buy-back - PME

21 February 24

Notification of cessation of securities - PME

×

Notification of cessation of securities - PME

21 February 24

Notification of cessation of securities - PME

×

Notification of cessation of securities - PME

21 February 24

Change of Director's Interest Notice - Alice Williams

×

Change of Director's Interest Notice - Alice Williams

20 February 24

Notification of buy-back - PME

×

Notification of buy-back - PME

20 February 24

Update - Notification of buy-back - PME

×

Update - Notification of buy-back - PME

20 February 24

Cancel - Notification of buy-back - PME

×

Cancel - Notification of buy-back - PME

16 February 24

Change of Director's Interest Notice - Alice Williams

×

Change of Director's Interest Notice - Alice Williams

15 February 24

Half Year Accounts

×

Half Year Accounts

15 February 24

Appendix 4D

×

Appendix 4D

15 February 24

Company Announcement - Interim Results

×

Company Announcement - Interim Results

15 February 24

Dividend/Distribution - PME

×

Dividend/Distribution - PME

15 February 24

CEO Interview - 1H24 results

×

CEO Interview - 1H24 results

15 February 24

HY24 Results Presentation

×

HY24 Results Presentation

05 February 24

PME launches Visage Ease VP for Apple Vision Pro

×

PME launches Visage Ease VP for Apple Vision Pro

PME Fundamentals

Per Share Records

Historical data

Forecasted data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Per Share, Growth & Valuations
EPS (Basic) $ Lock Lock Lock Lock 0.30 0.43 0.58 Lock Lock Lock
EPS (Fully Diluted) $ Lock Lock Lock Lock 0.30 0.42 0.58 Lock Lock Lock
     Growth % Lock Lock Lock Lock 33.4 43.8 36.4 Lock Lock Lock
     PE X Lock Lock Lock Lock 187.3 124.7 124.4 Lock Lock Lock
     EV/EBITDA X Lock Lock Lock Lock 118.3 80.4 79.8 Lock Lock Lock
CFPS $ Lock Lock Lock Lock 0.38 0.51 0.68 Lock Lock Lock
FCFPS $ Lock Lock Lock Lock 0.24 0.41 0.37 Lock Lock Lock
     Growth % Lock Lock Lock Lock 11.8 33.5 33.5 Lock Lock Lock
     Yield % Lock Lock Lock Lock 0.4 1.0 0.6 Lock Lock Lock
DPS $ Lock Lock Lock Lock 0.15 0.22 0.30 Lock Lock Lock
     Growth % Lock Lock Lock Lock 25.0 46.7 36.4 Lock Lock Lock
     Yield % Lock Lock Lock Lock 0.3 0.4 0.4 Lock Lock Lock
     Payout Ratio % Lock Lock Lock Lock 51 52 52 Lock Lock Lock
BPS $ Lock Lock Lock Lock 0.78 0.98 1.33 Lock Lock Lock
BPS (Tangible) $ Lock Lock Lock Lock 0.59 0.76 1.12 Lock Lock Lock
     Growth % Lock Lock Lock Lock 48.8 28.7 47.6 Lock Lock Lock
Shares Outstanding
Diluted m Lock Lock Lock Lock 105 105 105 Lock Lock Lock
Basic m Lock Lock Lock Lock 104 104 104 Lock Lock Lock

Financial Records

Historical data

Forecasted data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Income Statement
Sales $m Lock Lock Lock Lock 68 93 125 Lock Lock Lock
     Growth % Lock Lock Lock Lock 19.5 37.7 33.6 Lock Lock Lock
Selling & General Expenses $m Lock Lock Lock Lock 4 8 8 Lock Lock Lock
Gross Income $m Lock Lock Lock Lock 47 70 92 Lock Lock Lock
     Growth % Lock Lock Lock Lock 29.9 50.6 31.4 Lock Lock Lock
     Margin % Lock Lock Lock Lock 68.7 75.2 74.0 Lock Lock Lock
Cost of Goods Sold to Sales % Lock Lock Lock Lock 31 25 26 Lock Lock Lock
EBITDA $m Lock Lock Lock Lock 50 70 92 Lock Lock Lock
     Growth % Lock Lock Lock Lock 31.3 40.6 31.7 Lock Lock Lock
     Margin % Lock Lock Lock Lock 73.0 74.6 73.5 Lock Lock Lock
Depreciation & Amortisation $m Lock Lock Lock Lock 7 7 8 Lock Lock Lock
EBIT $m Lock Lock Lock Lock 42 62 84 Lock Lock Lock
     Growth % Lock Lock Lock Lock 41.0 47.2 34.4 Lock Lock Lock
     Margin % Lock Lock Lock Lock 62.4 66.8 67.2 Lock Lock Lock
Pretax Income $m Lock Lock Lock Lock 43 63 86 Lock Lock Lock
Income Taxes $m Lock Lock Lock Lock 12 19 25 Lock Lock Lock
Net Income $m Lock Lock Lock Lock 31 44 61 Lock Lock Lock
     Growth % Lock Lock Lock Lock 33.7 44.1 36.5 Lock Lock Lock
     Margin % Lock Lock Lock Lock 45.4 47.6 48.6 Lock Lock Lock
Cash Flow Statement
Net Operating Cash Flow $m Lock Lock Lock Lock 39 62 65 Lock Lock Lock
Capital Expenditures $m Lock Lock Lock Lock 8 9 6 Lock Lock Lock
Net Investing Cash Flow $m Lock Lock Lock Lock -27 -18 -10 Lock Lock Lock
Net Financing Cash Flow $m Lock Lock Lock Lock -14 -23 -28 Lock Lock Lock
Free Cash Flow $m Lock Lock Lock Lock 39 62 64 Lock Lock Lock
     Growth % Lock Lock Lock Lock 24.5 59.4 4.0 Lock Lock Lock
     Margin % Lock Lock Lock Lock 0.6 0.7 0.5 Lock Lock Lock
Franking Balance $m Lock Lock Lock Lock 4 5 13 Lock Lock Lock
Balance Sheet
Cash & Short-Term Investments $m Lock Lock Lock Lock 62 91 121 Lock Lock Lock
Total Assets $m Lock Lock Lock Lock 126 157 202 Lock Lock Lock
Long Term Debt $m Lock Lock Lock Lock 2 2 1 Lock Lock Lock
Net Debt $m Lock Lock Lock Lock -59 -88 -120 Lock Lock Lock
Total Liabilities $m Lock Lock Lock Lock 44 55 63 Lock Lock Lock
Equity $m Lock Lock Lock Lock 82 102 139 Lock Lock Lock
Invested Capital Lock Lock Lock Lock 84 103 140 Lock Lock Lock
     Growth % Lock Lock Lock Lock 35.2 23.5 35.4 Lock Lock Lock
Return Ratios
Return on Assets % Lock Lock Lock Lock 24.6 28.3 30.0 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock 37.8 43.7 43.7 Lock Lock Lock
Return on Total Capital % Lock Lock Lock Lock 57.8 66.3 68.6 Lock Lock Lock
Return on Invested Capital % Lock Lock Lock Lock 42.4 47.5 49.8 Lock Lock Lock
Cash Flow Return on Invested Capital % Lock Lock Lock Lock 53.6 66.5 53.2 Lock Lock Lock

Ratios Records

Historical data

Forecasted data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Leverage
Interest Cover X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Debt to EBITDA X Lock Lock Lock Lock -1.2 -1.3 -1.3 Lock Lock Lock
Net Debt to Equity % Lock Lock Lock Lock -72.5 -86.8 -86.2 Lock Lock Lock
Liquidity
Current Ratio X Lock Lock Lock Lock 5.0 4.5 5.3 Lock Lock Lock
Quick Ratio X Lock Lock Lock Lock 5.0 4.5 5.3 Lock Lock Lock
Cash & ST Inv/Current Assets % Lock Lock Lock Lock 70.6 75.6 74.2 Lock Lock Lock
CFO/Current Liabilities % Lock Lock Lock Lock 221.5 231.7 210.0 Lock Lock Lock
Balance Sheet Efficiency
Receivables Turnover X Lock Lock Lock Lock 3.3 3.6 3.6 Lock Lock Lock
Inventory Turnover X Lock Lock Lock Lock 615.2 417.7 493.0 Lock Lock Lock
Working Capital Turnover X Lock Lock Lock Lock 1.0 1.0 0.9 Lock Lock Lock
Payables Turnover X Lock Lock Lock Lock 1.3 1.8 0.8 Lock Lock Lock
Asset Turnover X Lock Lock Lock Lock 0.5 0.6 0.6 Lock Lock Lock
Du Pont
Asset Turnover X Lock Lock Lock Lock 0.5 0.6 0.6 Lock Lock Lock
x Pretax Margin % Lock Lock Lock Lock 63.2 67.5 69.0 Lock Lock Lock
= Pretax Return on Assets % Lock Lock Lock Lock 34.1 40.2 42.6 Lock Lock Lock
x Tax Rate Complement (1-Tax Rate) % Lock Lock Lock Lock 28.0 29.5 29.6 Lock Lock Lock
Return on Assets % Lock Lock Lock Lock 24.6 28.3 30.0 Lock Lock Lock
x Equity Multiplier (Assets/Equity) % Lock Lock Lock Lock 1.5 1.5 1.5 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock 37.8 43.7 43.7 Lock Lock Lock
x Earnings Retention (1-Payout) % Lock Lock Lock Lock 49.4 48.4 48.4 Lock Lock Lock
= Reinvestment Rate (%) % Lock Lock Lock Lock 18.6 21.1 21.1 Lock Lock Lock
Operating Cycle
Days of Inventory on Hand Days Lock Lock Lock Lock 0.6 0.9 0.7 Lock Lock Lock
+ Days of Sales Outstanding Days Lock Lock Lock Lock 111.3 102.1 100.2 Lock Lock Lock
Operating Cycle Days Lock Lock Lock Lock 111.9 103.0 100.9 Lock Lock Lock
- Days of Payables Outstanding Days Lock Lock Lock Lock 14.7 19.8 15.0 Lock Lock Lock
Net Operating Cycle Days Lock Lock Lock Lock 97.3 83.2 85.9 Lock Lock Lock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

.4%

Franking Level

100%

DPSg

36.40%

Quality Yield

Lock

Falling Divs over next 2

Lock

Expected Dividend Cashflow

Dividend Clarity,
Enhanced
Strategy

Upload your portfolio and gain access to 3-year dividend forecasts for each holding with HALO Global. Empower your decision-making and maximize returns with our advanced analytical tool. Try it today.

Values and Recommendations

Key Stats

Consensus Score

Lock

Recommendation

Lock

EPS 1 month Change

Lock

Quality Yield

Lock

Falling Divs over next 2

Lock

Halo Consensus Score

Lock Chart

PEG Ratio

Lock Chart

Consensus EPS Revisions

Lock Chart

Short selling

Key Stats

Percent of Issue

1.58%

Value ($M)

187

Prior Change

N/A

7 Day Change

N/A

1 Month Change

-0.20%

3 Month Change

0.10%

Discover
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

PME Shortsell

Frequently Asked Questions

The current share price of Pro Medicus, Ltd. (PME:ASX) is AU$116.9.
The 52-week high share price for Pro Medicus, Ltd. (PME:ASX) is AU$121.76.
The 52-week low share price for Pro Medicus, Ltd. (PME:ASX)? is AU$58.60.
The current TTM dividend payout for Pro Medicus, Ltd. (PME:ASX) is 0.40.
The last dividend payment of Pro Medicus, Ltd. (PME:ASX) is AU$0.18.
Pro Medicus, Ltd. (PME:ASX) has a franking level of 100.0%.
Pro Medicus, Ltd. (PME:ASX) is classified in the Healthcare.
The current P/E ratio for Pro Medicus, Ltd. (PME:ASX) is 124.40.